What is your treatment approach for hidradenitis suppurativa?
Do you reserve biologics for more systemic involvement? When do you initiate biologics such as secukinumab?
Answer from: at Academic Institution
In HS, we talk about a "window of opportunity." It's the idea that since HS causes tissue damage, scarring, and tunneling, treatment becomes more difficult as the disease progresses. A delay of 10 years between symptom onset and starting adalimumab was associated with a 1.92x higher odds that the pa...
Comments
at The University of Connecticut Health Center Based on the current evidence, do you have a prefe...
at Wayne State University It varies for each patient. If they have inflammat...
Based on the current evidence, do you have a prefe...
It varies for each patient. If they have inflammat...